## Inhalational Agents and Respiratory Effects in COPD **Key Point:** Sevoflurane is the MOST appropriate inhalational agent for patients with severe COPD and baseline hypercapnia due to its non-pungent nature, minimal airway irritation, and preservation of bronchomotor tone — avoiding the bronchospasm risk associated with desflurane. ### Comparative Respiratory Effects of Volatile Agents | Agent | MAC | Airway Irritation | Bronchospasm Risk | Emergence | Ideal for COPD | |-------|-----|-------------------|-------------------|-----------|----------------| | **Sevoflurane** | 2.0% | **None (non-pungent)** | **Low** | **Rapid** | **Yes** | | Desflurane | 6.0% | High (pungent) | High | Fastest | No | | Isoflurane | 1.15% | Moderate | Moderate | Slow | No | | Nitrous oxide | 104% | None | None | N/A | Limited (cannot be sole agent) | **High-Yield:** Desflurane is a pungent, airway-irritating agent that is well-documented to cause coughing, breath-holding, laryngospasm, and **bronchospasm** — particularly hazardous in patients with reactive airways or obstructive lung disease such as COPD. It is generally **contraindicated** as a maintenance agent in patients with significant airway reactivity (Miller's Anesthesia; Stoelting's Pharmacology & Physiology in Anesthetic Practice). ### Why Sevoflurane Is Best for COPD Patients 1. **Non-Pungent / Non-Irritating:** Sevoflurane does not stimulate airway reflexes, making it safe for patients with hyperreactive airways and obstructive physiology. 2. **Bronchodilatory Properties:** Sevoflurane has demonstrated bronchodilatory effects in patients with asthma and COPD, reducing airway resistance and improving ventilation-perfusion matching. 3. **Rapid Emergence:** Blood:gas solubility coefficient of 0.65 allows relatively rapid washout and early return of spontaneous ventilation — critical in a patient with baseline hypercapnia who is at risk for postoperative respiratory failure. 4. **Preserved Airway Reflexes on Emergence:** Because sevoflurane does not irritate the airway, patients emerge more smoothly with better preservation of protective reflexes compared to desflurane. **Clinical Pearl:** In patients with COPD, asthma, or any reactive airway disease, sevoflurane is the volatile agent of choice. Desflurane should be avoided due to its high pungency and documented risk of triggering bronchospasm (Stoelting's Pharmacology & Physiology in Anesthetic Practice, 5th ed.; Miller's Anesthesia, 8th ed.). ### Why Other Agents Are Suboptimal **Desflurane (MAC 6.0%):** - Highly pungent — causes airway irritation, coughing, laryngospasm, and bronchospasm - Contraindicated in patients with reactive airway disease or COPD - Despite rapid emergence, the risk of intraoperative bronchospasm outweighs this benefit in this patient **Isoflurane (MAC 1.15%):** - Moderate airway irritation; less pungent than desflurane but more than sevoflurane - Greater respiratory depression at equipotent doses - Slower emergence due to higher blood:gas solubility (1.4) - Not preferred in COPD when sevoflurane is available **Nitrous oxide (MAC 104%):** - Cannot be used as a sole anesthetic (MAC > 100%) - Must be combined with another agent - Provides minimal analgesia and amnesia alone - Risk of diffusion hypoxia on emergence; expands closed gas spaces (bullae in COPD — additional concern) ### Summary For a patient with severe COPD and baseline hypercapnia undergoing elective surgery, **sevoflurane** provides the optimal balance of: non-irritating airway profile, bronchodilation, adequate depth of anesthesia, and sufficiently rapid emergence to restore spontaneous ventilation promptly in the postoperative period.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.